Literature DB >> 11414314

Differential effects of ET-1, ET-2, and ET-3 on pancreatic microcirculation, tissue integrity, and inflammation.

T Plusczyk1, B Bersal, M D Menger, G Feifel.   

Abstract

The differential effects of endothelin-1, -2, and -3 (ET-1, ET-2, and ET-3) on pancreatic microcirculation, pancreatic tissue integrity, and an initial inflammatory response, which are three distinct characteristics of acute necrotizing pancreatitis, were investigated in a dose-dependent manner in rats using in vivo microscopy. Red blood cell (RBC) velocity and functional capillary density (FCD) were estimated after topical superfusion of the pancreas with ET-1, ET-2, and ET-3 (100, 10, 1 pmol), revealing that ET-1 (100, 10, 1 pmol) or high ET-2 (100 pmol) and ET-3 (100 pmol) cause a dose-related deterioration of exocrine nutritive pancreatic blood flow. Analysis of pancreatic exocrine tissue damage employing the Spormann score displayed that the ET-mediated microcirculatory impairment was paralleled by dose-dependent tissue damage, which was significant compared to the control group (topical superfusion with 1 ml, saline solution 0.9%). Estimation of pancreatic postcapillary leukocyte accumulation by histomorphologically counting choracetate esterase (CAE) stained leukocytes in 50 high-power fields per animal demonstrated a significant increase in postcapillary accumulation of white blood cells, after topical administration of ET-1, ET-2, and ET-3 compared to controls. In contrast to ET-caused effects on microcirculation and tissue impairment, quantitative analysis of postcapillary leukocyte accumulation revealed the most pronounced effect after ET-2 administration but not after ET-1 administration. This demonstrates that ET-1, ET-2, and ET-3 are all able to mediate microcirculatory impairment, tissue damage, and inflammation. However, ET-3-induced damaging effects are less pronounced, while ET-1 most severely alters microcirculation and ET-2 preferentially induces leukocyte-dependent inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11414314     DOI: 10.1023/a:1010640002323

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

Review 1.  Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines.

Authors:  B Battistini; M A Forget; D Laight
Journal:  Shock       Date:  1996-03       Impact factor: 3.454

2.  The application of stereological principles to morphometry of the microcirculation in different tissues.

Authors:  G W Schmid-Schoenbein; B W Zweifach; S Kovalcheck
Journal:  Microvasc Res       Date:  1977-11       Impact factor: 3.514

3.  Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia.

Authors:  A Giaid; S J Gibson; B N Ibrahim; S Legon; S R Bloom; M Yanagisawa; T Masaki; I M Varndell; J M Polak
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Localization of endothelinlike immunoreactivity and endothelin binding sites in human colon.

Authors:  H Inagaki; A E Bishop; C Escrig; J Wharton; T G Allen-Mersh; J M Polak
Journal:  Gastroenterology       Date:  1991-07       Impact factor: 22.682

5.  Effects of somatostatin (SMS) on pancreatic microcirculation.

Authors:  T Plusczyk; D Rathgeb; S Westermann; G Feifel
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

6.  Pancreatic acini possess endothelin receptors whose internalization is regulated by PLC-activating agents.

Authors:  P Hildebrand; J E Mrozinski; S A Mantey; R J Patto; R T Jensen
Journal:  Am J Physiol       Date:  1993-05

7.  An endothelin B receptor-selective antagonist: IRL 1038, [Cys11-Cys15]-endothelin-1(11-21)

Authors:  Y Urade; Y Fujitani; K Oda; T Watakabe; I Umemura; M Takai; T Okada; K Sakata; H Karaki
Journal:  FEBS Lett       Date:  1992-10-12       Impact factor: 4.124

8.  Effect of temporary ischemia upon development and histological patterns of acute pancreatitis in the rat.

Authors:  H Spormann; A Sokolowski; G Letko
Journal:  Pathol Res Pract       Date:  1989-05       Impact factor: 3.250

9.  Effect of endothelin-1 on the development of hemorrhagic pancreatitis in rats.

Authors:  X H Liu; T Kimura; H Ishikawa; H Yamaguchi; M Furukawa; I Nakano; M Kinjoh; H Nawata
Journal:  Scand J Gastroenterol       Date:  1995-03       Impact factor: 2.423

10.  Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.

Authors:  H Ehrenreich; R W Anderson; C H Fox; P Rieckmann; G S Hoffman; W D Travis; J E Coligan; J H Kehrl; A S Fauci
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Influencing factors of pancreatic microcirculatory impairment in acute panceatitis.

Authors:  Zong-Guang Zhou; You-Dai Chen
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

2.  Metabolic and vascular actions of endothelin-1 are inhibited by insulin-mediated vasodilation in perfused rat hindlimb muscle.

Authors:  Cathryn M Kolka; Stephen Rattigan; Stephen Richards; Michael G Clark
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

3.  Endothelin-1 receptor antagonist (LU-135252) improves the microcirculation and course of TNBS colitis in rats.

Authors:  Martin Kruschewski; Tanja Anderson; Christoph Loddenkemper; Heinz J Buhr
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

4.  Endothelin-1-mediated miR-let-7g-5p triggers interlukin-6 and TNF-α to cause myopathy and chronic adipose inflammation in elderly patients with diabetes mellitus.

Authors:  Chung-Huang Tsai; Pei-Ju Huang; I T Lee; Chien-Min Chen; Min Huan Wu
Journal:  Aging (Albany NY)       Date:  2022-04-25       Impact factor: 5.682

5.  Resveratrol Suppresses Severe Acute Pancreatitis-Induced Microcirculation Disturbance through Targeting SIRT1-FOXO1 Axis.

Authors:  Yuping Rong; Jun Ren; Wei Song; Renshen Xiang; Yuhang Ge; Wei Lu; Tao Fu
Journal:  Oxid Med Cell Longev       Date:  2021-02-09       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.